Within the GHS context, all beneficiaries are required to pay a small amount of money (Co-payment) per medicine they receive in order to avoid the phenomenon of over-prescribing and abuse, which, in addition to economic waste, may expose the patient to unnecessary risk. This amount of money cannot exceed a maximum amount of 150euro (or 75 euro for some beneficiary categories) per beneficiary and per annum, so as not to penalize people who need healthcare services often. This amount has been determined to one euro (€1 euro) per medicine and per prescription. Even in the event that the doctor prescribes two boxes of the same medicine due to increased dosage, the amount the beneficiary will pay is still 1 euro.
In addition to the Co-payment, beneficiaries may need to pay Contribution II. Contribution II is the cost difference between the cheapest alternative which is fully reimbursed by the GHS and the prescribed product.
If the beneficiary prefers the more expensive product, he/she will be burdened by the cost difference between the cheapest medicine, within a given category, and the prescribed medicine (Contribution II).
At least one product of every single category included in the Catalogue of Medicinal Products will be fully reimbursed by the GHS so that the beneficiaries will not need to pay Contribution II in the case they choose it.